Background: Dextromethorphan (DM), the d-isomer of the codeine analog levorphanol, is an active ingredient present in a variety of cough and cold remedies. Recently, data generated from a study in ...

The study was recently published in Science Translational Medicine and showed how dextromethorphan can impede the collagen that forms scars, inside cells, reducing lung fibrosis. Lung fibrosis ...

Scientists at EMBL discovered that Dextromethorphan, found in common cough syrups, shows promise in treating lung fibrosis.

Certain cough syrups contain dextromethorphan (DXM), which can cause altered mental states like: Hallucinations. Common ...

Axsome Therapeutics (NASDAQ:AXSM) stock fell 12% Monday after the company reported mixed Phase 3 results for its drug AXS-05, ...

Costco, the retail giant known for its bulk goods and beloved Kirkland brand, has initiated a recall of its Kirkland Si ...

New Delhi: Reviewing the justification for the Phase III clinical trial of Zydus Healthcare's fixed dose combination (FDC) pulmonary drug Dextromethorphan Hydrobromide plus Phenylephrine Hydrochloride ...

Johnson & Johnson has agreed to take over Intra-Cellular Therapies in a deal worth up to $14.6 billion – the second biopharma ...

Axsome Therapeutics, Inc. (NASDAQ:AXSM) released data from ACCORD-2, ADVANCE-2, and long-term safety trials AXS-05 ...

In its latest update of AXS-05, Axsome reported that the 295-patient phase 3 ACCORD-2 trial met its primary endpoint, with ...

Among significant news in a holiday spattered week, Dutch biotech argenx gained another approval in Japan for its Vyvdura ...

A new study has explored the potential of Dextromethorphan, an FDA-approved drug, in the treatment of lung fibrosis. Lung fibrosis occurs after accumulation of scar tissue in the lung (left image ...